NCT07018583Not yet recruiting
Pharmacist Counseling & Self-Management Program for Asthma Patients in a Midwest Chain Pharmacy, USA
The Effectiveness of Pharmacist's Counseling and Self-Management Application Program on Asthma Management Outcomes Among Asthma Patients at a Midwest Chain Pharmacy in Iowa, United States
Source: ClinicalTrials.gov · Last updated 27 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This clinical trial aims to evaluate the effectiveness of a pharmacist-led counseling and self-management application program on improving asthma management outcomes among adult patients with asthma receiving care at a Midwest chain pharmacy in Iowa, United States. The study investigates whether integrating the pharmacist counseling with self-management theory can enhance patients' medication adherence, asthma control, inhaler technique, and overall asthma awareness. These outcomes will be assessed at both 3 and 6 months after enrollment. Participants will be randomly assigned to one of two arms. The intervention group, which will receive a comprehensive pharmacist-led counseling program supported by a mobile application ("Don R.Ph Application"). The control group, which will receive standard pharmacy care as per usual practice.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- First submitted
- 4 Jun 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 28 Feb 2026
- Lead sponsor
- Nakhon Ratchasim Rajabhat University
- Diseases
- Asthma
- NCT number
- NCT07018583
What you commit to
- Study type: Interventional
- Planned participants: 84
- From 1 Aug 2025 to the primary completion date, 28 Feb 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- The patient with one of the following - coronary heart disease, severe hypertension, severe heart failure, severe musculoskeletal disorder, mental health condition, dementia, chronic obstructive lung disease, or COVID-19.
Age
- The adult patient with asthma aged \< 25 years or \> 64 years old.
Other
- Participating in another "Pharmacy Counseling or Education Program."
- The patient does not have a smartphone (iOS or Android).
- The patient does not have sufficient comprehension or the ability to communicate effectively in English.
- The patient is unwilling or unable to participate in the entire program.
Who the study is looking for
- Adult patients with asthma are 25 - 64 years of age.
- Have been receiving medications from the pharmacy of either Inhaled Corticosteroids (ICS) or a fixed combination of ICS with a long-acting beta-agonist (bronchodilator) and regular patronage of the pharmacy for the previous six months.
- Confirmed diagnosis from either the physician's diagnosis or the patient's self-report.
- No respiratory comorbidities (i.e., COPD or lung diseases).
- Uses a smartphone (IOS or Android).
- Ability to communicate with the pharmacist in English.
- Volunteer to participate in the program for the period.
Age in the registry: 25 years to 64 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.